Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | |
|---|---|---|---|---|---|---|---|
| Total revenue | |||||||
| Cost of revenue | |||||||
| Gross profit | |||||||
| Operating expense | 77.21%1.85M | -19.22%1.04M | -13.07%1.29M | -18.37%1.48M | 35.31%1.82M | 1.24%1.34M | 1.33M |
| Selling and administrative expenses | 31.02%1.36M | -18.76%1.04M | -12.52%1.28M | 116.58%1.47M | -12.62%676.48K | -41.16%774.18K | --1.32M |
| -General and administrative expense | 31.02%1.36M | -18.76%1.04M | -12.52%1.28M | 116.58%1.47M | -12.62%676.48K | -41.16%774.18K | --1.32M |
| Depreciation amortization depletion | ---- | ---- | ---- | -74.96%7.71K | -29.70%30.79K | 832.91%43.8K | --4.7K |
| -Depreciation and amortization | ---- | ---- | ---- | -74.96%7.71K | -29.70%30.79K | 832.91%43.8K | --4.7K |
| Other operating expenses | --480.93K | ---- | -26.55%7.43K | -99.09%10.11K | 111.46%1.11M | 8,966.36%524.67K | --5.79K |
| Operating profit | -77.21%-1.85M | 19.22%-1.04M | 13.07%-1.29M | 18.37%-1.48M | -35.31%-1.82M | -1.24%-1.34M | -1.33M |
| Net non-operating interest income (expenses) | 1,625.00%10.28K | 893.33%596 | -97.45%60 | -55.56%2.36K | -79.48%5.3K | 103.14%25.83K | -821.78K |
| Non-operating interest income | 1,625.00%10.28K | 893.33%596 | -97.45%60 | -55.56%2.36K | -81.12%5.3K | -48.22%28.08K | --54.22K |
| Non-operating interest expense | ---- | ---- | ---- | ---- | ---- | -99.74%2.24K | --876K |
| Other net income (expenses) | 245.61%86.76K | 25.1K | |||||
| Other non-operating income (expenses) | ---- | ---- | ---- | ---- | 245.61%86.76K | --25.1K | ---- |
| Income before tax | -76.32%-1.83M | 19.27%-1.04M | 12.48%-1.29M | 13.05%-1.47M | -35.74%-1.69M | 41.77%-1.25M | -2.14M |
| Income tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Earnings from equity interest net of tax | |||||||
| Net income | -76.32%-1.83M | 19.27%-1.04M | 12.48%-1.29M | 13.05%-1.47M | -35.74%-1.69M | 41.77%-1.25M | -2.14M |
| Net income continuous operations | -76.32%-1.83M | 19.27%-1.04M | 12.48%-1.29M | 13.05%-1.47M | -35.74%-1.69M | 41.77%-1.25M | ---2.14M |
| Noncontrolling interests | |||||||
| Net income attributable to the company | -76.32%-1.83M | 19.27%-1.04M | 12.48%-1.29M | 13.05%-1.47M | -35.74%-1.69M | 41.77%-1.25M | -2.14M |
| Preferred stock dividends | |||||||
| Other under preferred stock dividend | |||||||
| Net income attributable to common stockholders | -76.32%-1.83M | 19.27%-1.04M | 12.48%-1.29M | 13.05%-1.47M | -35.74%-1.69M | 41.77%-1.25M | -2.14M |
| Diluted earnings per share | |||||||
| Basic earnings per share | |||||||
| Dividend per share | |||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |